Old Web
English
Sign In
Acemap
>
authorDetail
>
Mark A. Meservey
Mark A. Meservey
Parke-Davis
Microbiology
antibacterial agent
Ciprofloxacin
Biology
Haemophilus influenzae
4
Papers
34
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy of quinolones in preventing Staphylococcus aureus-induced abscess in mice
1995
Journal of Antimicrobial Chemotherapy
Michael A. Cohen
Jeffrey W. Gage
Michael D. Huband
Mark A. Meservey
Steven VanderRoest
Steven L. Yoder
Show All
Source
Cite
Save
Citations (7)
In vitro evaluation of cefdinir (FK482), a new oral cephalosporin with enhanced antistaphylococcal activity and β-lactamase stability
1994
Diagnostic Microbiology and Infectious Disease
Michael A. Cohen
E.Themis Joannides
Gregory E. Roland
Mark A. Meservey
Michael D. Huband
Martin A. Shapiro
Josephine C. Sesnie
Carl L. Heifetz
Show All
Source
Cite
Save
Citations (17)
In vivo therapeutic efficacy of cefdinir (FK482), a new oral cephalosporin, against Staphylococcus aureus and Haemophilus influenzae in mouse infection models
1994
Diagnostic Microbiology and Infectious Disease
Michael A. Cohen
Sara A. Wold
Mark A. Meservey
Jeffrey W. Gage
Carl L. Heifetz
Gail B. Mailloux
Gregory E. Roland
Steven L. Yoder
Show All
Source
Cite
Save
Citations (1)
In vitro antibacterial activities of PD 138312 and PD 140248, new fluoronaphthyridines with outstanding gram-positive potency.
1993
Antimicrobial Agents and Chemotherapy
Michael D. Huband
Michael A. Cohen
Mark A. Meservey
Gregory E. Roland
Steven L. Yoder
M E Dazer
John M. Domagala
Show All
Source
Cite
Save
Citations (9)
1